Under construction – not a live service
Sign in

What researchers published on Huntington's disease

735 papers, newest first.

Showing 160 of 735

  • Not labelled yetSuperpixel-ComBat multi-site harmonization of unpaired T1W MRI data in Huntington's disease.Neuroimage. Reports
  • ReviewMiro1 and mitochondrial dysfunction in Huntington's disease: Emerging mechanistic links and therapeutic perspectives.Mitochondrion
  • Not labelled yetQualitative insights from partners of individuals with Huntington's disease: the quality of life of an under-researched population.Orphanet journal of rare diseases
  • Not labelled yetPrimer site variations resulting in false-negative Huntington's disease testing.Journal of medical genetics
  • Not labelled yetIsozyme-Specific Inhibition of GSK-3 Reveals Distinct Cellular Responses in Huntington's Disease Fibroblasts.Journal of neurochemistry
  • Not labelled yetThe SorCS2-derived macrocycle TT-P34 drives neuroprotection in animal models of neurodegeneration.Acta neuropathologica communications
  • ReviewThe hepatic secretome-microglia axis in huntington's disease: Linking peripheral metabolic dysfunction to neuroinflammation and novel therapeutic opportunities.Metabolic brain disease
  • Not labelled yetIn vivo assessment of brain microstructure in patients with Huntington's disease using quantitative MRI.Journal of neurology
  • Not labelled yetNeuroD1-induced fate conversion partially restores GABAergic neuronal identity in Huntington's disease.Molecular therapy : the journal of the American Society of Gene Therapy
  • Not labelled yetForecasting and Dynamics of Huntington's disease: A Machine Learning approach for Fractional-Order Mathematical Model.Journal of advanced research
  • Not labelled yetThe Treatment of Psychiatric Symptoms in Huntington's Disease: A Systematic Review.Current neuropharmacology
  • Not labelled yetRhes as a Potential Modulator of PINK1/Parkin-Dependent Mitophagy in Huntington's Disease.Journal of integrative neuroscience
  • Not labelled yetThe postsynaptic scaffolding protein SAPAP3 shapes mitochondrial activity: the case of Huntington's disease.Cell death & disease
  • Not labelled yetCell-specific transcription dysregulation in human Huntington's disease-positive developing striatum.Brain : a journal of neurology
  • Not labelled yetBioinformatics Analysis to Reveal Potential Targets of Huntington's Disease.IET systems biology
  • Not labelled yetCSF Leukocytes Transiently Increase Before Onset of Huntington Disease in Association With a Stage-Specific CSF Cytokine/Chemokine Pattern.Neurology(R) neuroimmunology & neuroinflammation
  • Not labelled yetComputational modeling and preclinical evaluation support targeting somatic instability for Huntington's disease treatment.Nature communications
  • Not labelled yetSomatic DNA-repeat expansions initiate distinct yet analogous changes in Huntington's disease cortical and striatal neurons.Cell
  • Not labelled yetMultimodal spatial transcriptomics redefines cortical pathology in Huntington's disease.Cell
  • ReviewNeuroprotective roles of Klotho signaling in Huntington's disease: From molecular insights to clinical translation.IBRO neuroscience reports
  • Not labelled yetEarly Administration of Methylene Blue Attenuates Mitochondrial Dysfunction and Cognitive Deficits in a Model of Huntington's Disease.Biology
  • Not labelled yetShould Huntington's Disease Remains the First Genetic Consideration in Adults Presenting with Combined Chorea and Ataxia in Resource-Limited Settings?Movement disorders clinical practice
  • Not labelled yetQuantifying multidisciplinary collaboration in Huntington's disease before and after service redesign: a social network analysis.BMC health services research
  • Not labelled yetHD-DRUM Rhythmic Training in Huntington's Disease: Feasibility, Motor, and Brain Microstructural Pilot Signals.Movement disorders clinical practice
  • PreprintCerebrospinal Fluid Myeloperoxidase Is Associated With Putamen Volume Beyond Neurofilament Light in Huntington's Disease.medRxiv : the preprint server for health sciences
  • Randomised trialAntidopaminergic Medications and Clinical Outcomes in Huntington Disease: Evidence From the PROOF-HD Placebo-Controlled Trial.Neurology
  • Not labelled yetHealthcare trajectories diverge years before Huntington disease is recorded in claims: a nationwide French matched cohort study.Journal of neurology, neurosurgery, and psychiatry
  • Not labelled yetEmotion regulation difficulties are selectively associated with executive and behavioural apathy in Huntington's disease.Journal of neurology
  • Not labelled yetBeyond Clinical Outcomes: What Antidopaminergic Medications Teach Us About Causal Inference in Huntington Disease.Neurology
  • Not labelled yetProgenitor transcriptional alterations link fetal and adult pathology in Huntington's disease.Brain : a journal of neurology
  • ReviewBeyond inherited repeat length: somatic expansions in Huntington disease.Current opinion in genetics & development
  • Not labelled yetCas9 nickase-mediated contraction of CAG/CTG repeats is associated with phenotypic improvements in a Huntington's disease mouse model.Science translational medicine
  • ReviewThe potential of AI inspired approaches for patient monitoring in drug development for Huntington's disease: capturing the digital exhaust for activities of daily living.Frontiers in molecular medicine
  • Not labelled yetAutonomic dysfunction in patients with Huntington's disease: Evidence from standardized cardiovascular reflex testing.Journal of Huntington's disease
  • Not labelled yetHuntington's disease clinical trials update: August 2026.Journal of Huntington's disease
  • ReviewNeuroprotective Role of Withaferin A in Huntington's Disease: Current Evidence and Future Perspectives.Molecular neurobiology
  • Not labelled yetThe Power of Two: Combined MSH3/HTT Silencing in Huntington's Disease.Movement disorders : official journal of the Movement Disorder Society
  • Not labelled yetiPSC neurodegenerative disease initiative isogenic CAG repeat iPSC line for Huntington's disease.Journal of Huntington's disease
  • Not labelled yetAttentional emotional bias in Huntington's disease: The "Hyper-Positive" effect.Cognitive, affective & behavioral neuroscience
  • Not labelled yetNeurofilament Light Chain and Mutant Huntingtin Across Huntington's Disease Integrated Staging System Stages in Huntington Disease: A Cross-Sectional Multimodal Analysis.Movement disorders : official journal of the Movement Disorder Society
  • Not labelled yetRecent Advances in Pharmacological Interventions for Huntington's Disease: Evidence from Clinical Translation.Reviews on recent clinical trials
  • Not labelled yetHuntington's disease vasculopathy is barrier-type-selective and arteriolar-dominant with spatially-coupled astrogliosis and reversible by S1pr1 stimulation.Nature communications
  • Not labelled yetUnmasking Huntington Disease: How a Neuropsychiatric Crisis Overcame Cultural Barriers to a Delayed Diagnosis.Clinical case reports
  • Not labelled yetRole of Miro1 in Mitochondrial Dysfunction and Neurodegeneration in Huntington's Disease.Current neurovascular research
  • Case reportJuvenile Huntington Disease With Cerebellar-Predominant Atrophy Identified by Genome Sequencing.Annals of clinical and translational neurology
  • Not labelled yetStriatal astrocyte μ-crystallin (Crym) loss contributes to early-stage Huntington's disease pathophysiology.Neuron
  • Not labelled yetPlasma Lipid Remodeling across Preclinical Burden, Disease Onset, and Early Motor Severity in Huntington's Disease.Movement disorders : official journal of the Movement Disorder Society
  • PreprintEffect of Vesicular Monoamine Transporter Type-2 Inhibitors on Motor Features in HD.medRxiv : the preprint server for health sciences
  • Not labelled yetSafety and efficacy of SOM3355 in patients with Huntington's disease (SOMCT03): a phase 2b, randomised, placebo-controlled, multicentre, dose-ranging study.EClinicalMedicine
  • PreprintDepletion of border-associated macrophages impairs CSF flow and exacerbates extranuclear mutant Huntingtin aggregation in the zQ175DN mouse model of Huntington's disease.bioRxiv : the preprint server for biology
  • Not labelled yetPellagra encephalopathy in Huntington disease: An autopsy case.Journal of neuropathology and experimental neurology
  • Not labelled yetJoint Analysis for Multivariate Longitudinal and Event Time Data With a Change Point Anchored at Interval-Censored Event Time.Statistics in medicine
  • Not labelled yetStaging disease without illness: ethical issues of the Huntington's Disease Integrated Staging System (HD-ISS).Journal of medical ethics
  • ReviewMonitoring huntingtin aggregation in Huntington's disease: methods, challenges and future opportunities.Expert review of proteomics
  • ReviewExtracellular Vesicles and Exosomes as Biomarkers in Huntington's Disease: Uncovering Pathogenic Insights and Pioneering Therapies.Molecular neurobiology
  • ReviewHope or hype: novel disease-modifying treatments for Huntington disease.Parkinsonism & related disorders
  • Not labelled yetNationwide survey and epidemiology of Huntington's disease in Hungary.Neuroepidemiology
  • Not labelled yetLycium barbarum glycopeptide alleviates the neuropathology in Huntington's disease mouse models.Neural regeneration research
  • ReviewChaperone-mediated remodelling of mutant huntingtin.Philosophical transactions of the Royal Society of London. Series B, Biological sciences
  • ReviewMechanistic Differences in Adult-Onset and Juvenile-Onset Huntington's Disease and the Potential Role of Neurodevelopment.Cureus
  • PreprintRestoring Aquaporin-4 alleviates molecular and motor phenotypes in zQ175 mouse model of Huntington's disease.bioRxiv : the preprint server for biology
  • PreprintComputer vision-aided locomotor behavioral analysis identifies therapeutic motor signatures in a mouse model of Huntington's disease.bioRxiv : the preprint server for biology
  • Not labelled yetAgentic AI for Clinical Outcomes Research, Population Health Management Analyses With Large Administrative Databases, and Generating Epidemiological Estimates of Diseases: Feasibility and Validation Study.Journal of medical Internet research
  • ReviewZebrafish as an Alternative Animal Model of Huntington's Disease: Challenges and Future Directions.Journal of integrative neuroscience
  • Not labelled yetDevelopment of Antisense Gapmers for the Treatment of Huntington's Disease.Methods in molecular biology (Clifton, N.J.)
  • Not labelled yetSex-dependent mild cardiac dysfunction and neurometabolic abnormalities in a model of Huntington's disease.Disease models & mechanisms
  • ReviewEstrogen and progesterone receptor signaling as candidate neuroendocrine modulators in Huntington's disease.Neurodegenerative disease management
  • Not labelled yetMasking phosphatidylserine prevents neuronal loss in two distinct Drosophila models of neurodegeneration.Proceedings of the National Academy of Sciences of the United States of America
  • Not labelled yetExpression of mutant Huntingtin induces proteasomal defects, mitochondrial abnormalities, and cell death in Drosophila muscles.Biochemical and biophysical research communications
  • ReviewPlanning advanced therapy trials for Huntington's disease: Ethical considerations.Molecular therapy : the journal of the American Society of Gene Therapy
  • Not labelled yetCorrection: Remote smartphone-based spoken language screening predicts clinical markers in Huntington's disease.Journal of neural transmission (Vienna, Austria : 1996)
  • ReviewUncovering hidden protein networks in Huntington's disease: implications for pathogenesis and therapy.Molecular biology reports
  • Not labelled yetExploring factors that influence meal management and eating behaviours in people living with Huntington's disease.Disability and rehabilitation
  • ReviewDefective membrane dynamics in Huntington's disease: A role of Rab11 dysfunction.Journal of Huntington's disease
  • Case reportChorea-predominant SCA5 mimicking Huntington's disease: A case report with a novel SPTBN2 variant.Clinical parkinsonism & related disorders
  • Not labelled yetmiR-196a reduces mutant Huntingtin aggregates by Rad23b-mediated degradation in Huntington's disease.Journal of biomedical science
  • ReviewFluid and Imaging Biomarkers in Huntington's Disease.Current neurology and neuroscience reports
  • ReviewImaging the glymphatic system in Huntington's disease: The benefits of a multimodal approach and clinical implications.International review of neurobiology
  • ReviewIndoleamine 2,3-dioxygenase 1 inhibitors: Molecular pharmacology, structural biology and medicinal chemistry with therapeutic perspectives for Huntington's disease.Biochimica et biophysica acta. Proteins and proteomics
  • Not labelled yetuniQure Submits U.S., U.K. Applications for Huntington's Disease Candidate.Human gene therapy
  • Not labelled yetEsketamine for treatment of depression in Huntington's disease: A case report.Journal of Huntington's disease
  • Not labelled yetMeal timing as medicine: clinical evidence for intermittent fasting in Huntington's disease.Nature metabolism
  • Trial resultEffects of time-restricted eating in early-stage Huntington's disease: a pilot study.Nature metabolism
  • Not labelled yetVisualizing Synaptic Disruptions in the Release and Regulation of Dopamine Hotspots in Huntington's Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience
  • Not labelled yetAn Atlas of Modifiers of Age at Onset in Huntington's Disease.Current neuropharmacology
  • Not labelled yetLoss of interruption in the HTT CAG repeat is associated with somatic expansion and loss of medium spiny neurons in Huntington's disease.Neuron
  • Not labelled yetDecreased cerebrospinal fluid TNFRSF8 (sCD30) confirmed as a biomarker of Huntington's disease progression.Journal of neurology
  • Not labelled yetThe Trail Making Test in healthy controls and Huntington's disease: Demographic effects and normative tables based on a large data set.Psychological assessment
  • Not labelled yetEvaluation of curcumin as an exploratory pharmacological tool for modulating dysregulated molecular pathways in cellular models of Huntington's disease.Molecular biology reports
  • Not labelled yetNeuroimaging Findings in Three Patients with Juvenile Huntington's Disease.AJNR. American journal of neuroradiology
  • ReviewMicroRNAs in polyglutamine diseases: Mechanistic insights, circulating biomarkers, and emerging microRNA-based therapeutic strategies.Neurobiology of disease
  • Not labelled yetSesamum indicum-derived valdiate as a novel neuroprotective agent targeting PDE10A2 and SIRT1 in Huntington's disease.Frontiers in bioinformatics
  • Not labelled yetCombining Lycopene, Quercetin, and Poloxamer 188 Therapy Reduces Learning and Memory Deficits in the 3-nitropropionic Acid-induced Rat Model of Huntington's Disease.CNS & neurological disorders drug targets
  • Not labelled yetIdentification of Age-Associated Upstream Regulators to Promote Neuronal Resilience in HD Patient-Derived Neurons.Neuroscience bulletin
  • Not labelled yetTargeting Klotho Signaling for Neuroprotection in Huntington's Disease: A Comprehensive Review.Current molecular medicine
  • Not labelled yetNanotechnological and in vivo characterization of a new generation of brain-permeable nanoparticles for brain-targeted cholesterol delivery in Huntington's disease.International journal of pharmaceutics
  • Not labelled yetMapping brain volume changes in the zQ175DN mouse model of Huntington's disease: a longitudinal MRI study.Biomarker research
  • Not labelled yetPsychological interventions for individuals affected by Huntington's disease: effects on depression, anxiety, and emotional well-being.Journal of community genetics
  • Not labelled yetCross-species single-cell atlas of the striatum defines cell-type and subregion disease vulnerabilities.Cell
  • Not labelled yetMultimodal Characterization of Glymphatic-Related Magnetic Resonance Imaging Markers in Huntington's Disease: A Multi-Cohort Retrospective Study.Annals of neurology
  • Not labelled yetUnawareness of motor deficit in Huntington's disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
  • Not labelled yetHuman-specific sequence features in HTT exon 1 promote toxic misprocessing via splicing factor SRSF7.Nature communications
  • Not labelled yetL-theanine from Camellia sinensis (L.) attenuates 3-NP-induced Huntington's disease-like alterations by remedying behavioral patterns and modulating neurotransmitters across three distinct brain regions: evidence from in-vivo and in-silico approaches.Metabolic brain disease
  • Not labelled yetA Cost-Effectiveness Analysis for Treatments of Patients with Early Stage Huntington's Disease in the USA.PharmacoEconomics - open
  • Case reportEarly Manifestations, Diagnostic Pathways, and Epilepsy in Juvenile-Onset Huntington Disease: A Three-Patient Case Series and Systematic Review.Brain sciences
  • Not labelled yetEarly reduction of myelin-associated glycoprotein at myelin membranes in Huntington's disease.Experimental neurology
  • ReviewRevealing the Mechanisms of Alzheimer's, Parkinson's and Huntington's Diseases Through Invertebrate Models.Biology
  • Not labelled yetGeometric properties of caudate and putamen mark the progression of Huntington's disease.Imaging neuroscience (Cambridge, Mass.)
  • ReviewThe pathophysiology of depression in Huntington's disease.Neuroscience and biobehavioral reviews
  • Not labelled yetDecoding neuronal vulnerability: Multidimensional analysis of D1R- and D2R- medium-sized spiny neurons in Huntington's disease.Brain pathology (Zurich, Switzerland)
  • ReviewUnraveling Neurodegeneration: Common Molecular Mechanisms and Novel Therapeutic Concepts in Major Neurodegenerative Disorders.Brain and behavior
  • Not labelled yetA porcine spectral assay library to quantify brain proteome by DIA-MS.Scientific data
  • Not labelled yetNetwork-based stratification of allele-specific expression reveals patient subgroups in Huntington's disease.Bioinformatics (Oxford, England)
  • ReviewHuntingtin, signaling endosomes and neuronal survival in health and Huntington disease.Journal of Huntington's disease
  • ReviewDysfunction of Primary Cilium in Huntington's Disease: How Mutant Huntingtin Disrupts This Cellular Signaling Hub.Biochemistry. Biokhimiia
  • Systematic reviewThe Role of MicroRNA in Diagnosis of Huntington's Disease: A Systematic Review.Molecular neurobiology
  • Not labelled yetIndicators of need and timing of percutaneous endoscopic gastrostomy (PEG) in people with Huntington's disease: A medical chart review study.Journal of Huntington's disease
  • PreprintTargeted quantification assays for DNA repair and handling proteins and interactions in Huntington's disease models.bioRxiv : the preprint server for biology
  • Not labelled yetIntracerebroventricular Administration of Gangliosides for In Vivo Functional Studies in Mice.Methods in molecular biology (Clifton, N.J.)
  • ReviewThe potential of vitamins in Huntington's disease: bridging mechanistic evidence with translational limitations and future strategies.Metabolic brain disease
  • Not labelled yetThe Role of PolyQ in Global Conformational Dynamics and Stability of Huntingtin.ACS chemical neuroscience
  • ReviewCurrent landscape and future perspectives of small-molecule therapeutics for Huntington's disease: From rational design to clinical translation.European journal of medicinal chemistry
  • Not labelled yetMultimodal balance training with rhythmical auditory cueing in Huntington's disease: A pilot randomized controlled trial.Journal of Huntington's disease
  • Not labelled yetDissociable Effects of Dysarthria Etiology and Severity on the Minimally Detectable Change of Speech Intelligibility.Journal of speech, language, and hearing research : JSLHR
  • Observational studyCSF Leukocytes Transiently Increase Before Onset of Huntington Disease in Association With a Stage-Specific CSF Cytokine/Chemokine Pattern.Neurology(R) neuroimmunology & neuroinflammation
  • ReviewMitochondrial dynamics in Huntington's disease.Journal of Huntington's disease
  • Not labelled yetReal-world treatment patterns and outcomes of deutetrabenazine in patients with chorea associated with Huntington disease: A retrospective chart review study.Journal of Huntington's disease
  • ReviewAlternative splicing dysregulation in CAG repeat expansion diseases.Trends in neurosciences
  • Not labelled yetCholesterol restores corticostriatal synaptic connectivity in Huntington's disease through BDNF/TrkB signalling, supporting a role for cholesterol pathways implicated by human genetic modifier studies.Pharmacological research
  • Not labelled yetBlocking somatic repeat expansion and lowering huntingtin by RNAi synergize to attenuate Huntington's disease pathogenesis in mice.Science translational medicine
  • Not labelled yetMissed Opportunities for Goals-of-Care Conversations in a Patient With End-Stage Juvenile Huntington's Disease: A Case Report.The American journal of hospice & palliative care
  • Not labelled yetIn vivo mapping of striatal neurodegeneration in Huntington's disease with Soma and Neurite Density Imaging.eLife
  • Not labelled yetEmerging Pharmacological Therapies for Huntington's Disease: Translational Insights from Recent Clinical Trials.Current pharmaceutical biotechnology
  • Not labelled yetAn automated speech measure for Huntington's disease: how can it take the field forward?The Lancet. Digital health
  • Not labelled yetEarly Longitudinal Brain Network Changes in Huntington's Disease Before Clinical Motor Onset.Movement disorders : official journal of the Movement Disorder Society
  • Not labelled yetGelatin methacryloyl hydrogel as a potential scaffold for cell transplantation for Huntington's disease.Brain communications
  • Not labelled yetWild-type C9orf72 drives proteasomal dysfunction and mutant aggregates via a Stat1-Isg15 axis in Huntington's disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
  • Not labelled yetJuvenile-onset Huntington's disease: a challenging diagnosis.Practical neurology
  • Not labelled yetGut microbiome composition in Huntington's disease: Stage-dependent differences between premanifest and manifest patients.Life sciences
  • Not labelled yetCholesterol nose-to-brain delivery as a possible therapeutic strategy in Huntington's disease.Translational neurodegeneration
  • ReviewMolecular insights of peroxisome proliferator-activated receptor-γ signalling in amyotrophic lateral sclerosis and Huntington's disease.International review of neurobiology
  • Not labelled yetAltered myelin sphingolipid and glycerophospholipid profiles in Huntington disease.Journal of Huntington's disease
  • ReviewWhat can clinical disorders involving the basal ganglia tell us about the pathophysiology of obsessive and compulsive symptoms?Journal of neural transmission (Vienna, Austria : 1996)
  • Not labelled yetEnhancing the detection of HTT1a with neoepitope antibodies in mouse models of Huntington's disease.Brain communications
  • Not labelled yetFalls in Huntington's Disease: A Cross-Sectional Analysis of Clinical Features and Potential Contributors.Movement disorders clinical practice
  • Not labelled yetAccelerated prefrontal intermittent theta-burst stimulation in Huntington's disease: a within-subject study of domain-specific behavioral and event-related potential changes.Frontiers in human neuroscience
  • Not labelled yetRevisiting the Link Between Huntington's Disease and Cancer: Evidence from the Enroll-HD dataset.Neuroepidemiology
  • Not labelled yetIn vivo CRISPR base editing for treatment of Huntington's disease.Nature biomedical engineering
  • Not labelled yetPsychosis in Huntington's disease: A case supporting multidisciplinary and early palliative care.Journal of Huntington's disease
  • Not labelled yetHDDF2-A Novel Patient-Derived Fibroblast Line from Huntington's Disease with Prominent Cellular Senescence and polyQ Pathology.Biomedicines
  • ReviewGrape Seed Extract as an Adjuvant Therapy for Huntington Disease; A Narrative Review of Biological Plausibility and Potential Clinical Outcomes.Molecules (Basel, Switzerland)
  • Not labelled yetPrevention of appearance of severe Huntington's disease symptoms in the R6/1 mouse model by early administration of 4',5,7-trihydroxyisoflavone.Journal of Huntington's disease
  • Not labelled yetIL17A disrupts autophagy-lysosomal function and lysosome reformation through the GSK3B-TFE3 signaling pathway in Huntington disease.Autophagy
  • Not labelled yetA novel machine learning approach for the classification of Huntington disease manifestation using motor features.Parkinsonism & related disorders
  • Not labelled yetA deep learning model for speech-based prediction of clinical scores in people with Huntington's disease: a longitudinal study with cross-sectional replication.The Lancet. Digital health
  • Not labelled yetDo young carriers of Huntington's disease mature earlier?Journal of Huntington's disease
  • ReviewMachine learning applications in Huntington's disease prognosis: A review.Journal of Huntington's disease
  • Not labelled yetRelationship Between miRNA and Neurodegenerative Diseases Such as Alzheimer's disease, Parkinson's, Huntington's disease, Amyotrophic Lateral Sclerosis.Mini reviews in medicinal chemistry
  • Not labelled yetUSP28 Deficiency is Linked to Impaired Ubiquitin-dependent Proteostasis in Huntington's Disease.Molecular neurobiology
  • ReviewFrom glycemic control to neuroprotection: alogliptin as a repurposed candidate for Huntington's disease.Metabolic brain disease